Based on client feedback and validation, CME Group is launching 'SOFR First for Options', a market-wide initiative geared toward accelerating adoption and liquidity in SOFR options during the months of June and July. The details of this initiative are presented in the on-demand webinar below, featuring CME Group's Agha Mirza and Sean Tully, with remarks from Nate Wuerffel of the Federal Reserve Bank of New York and David Bowman of the Federal Reserve Board of Governors.
Managing Director and Global Head of Rates and OTC Products, CME Group
Mr. Mirza is responsible for leading CME Group’s Rates and OTC business strategy globally, including growing volume and revenue through client-driven new product development, product extensions and electronic trading optimization.
Senior Managing Director, Global Head of Rates and OTC Products, CME Group
Mr. Tully is responsible for leading the development, execution, and management of CME Group’s interest rate, cash, and OTC products portfolio.
Senior Associate Director, Board of Governors of the Federal Reserve System
Mr. Bowman serves as the Board’s senior staff liaison to the Alternative Reference Rates Committee, convened by the Board of Governors and Federal Reserve Bank of New York to help identify alternatives to LIBOR and to develop strategies to promote their use.
Senior Vice President, Head of Domestic Markets, Markets Group, Federal Reserve Bank of New York
Mr. Wuerffel is responsible for the Money Markets, Mortgage Markets, and Treasury Markets trading desks, which carry out monetary policy operations as directed by the FOMC and provide fiscal agent services to the U.S. Treasury.
The information herein has been complied by CME Group for general informational and education purposes only and does not constitute trading advice or the solicitation of purchases or sale of futures, options, swaps, any other financial instrument, or financial service. The views in this video reflect solely those of the author or speaker and not necessarily those of CME Group or its affiliated institutions. All examples discussed are hypothetical situations, used for explanation purposes only, and should not be considered investment advice of the results of actual market experience. Although every attempt has been made to ensure the accuracy of the information herein, CME Group and its affiliates assume no responsibility for any errors or omissions. All data is sourced by CME Group unless otherwise stated. All matters pertaining to rules and specification herein are made subject to and are superseded by applicable CME Group rules. Current rules should be consulted in all cases concerning contract specifications.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. All other trademarks are the property of their respective owners.
Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Swaps trading should only be undertaken by investors who are Eligible Contract Participants (ECPs) within the meaning of Section 1a(18) of the Commodity Exchange Act. Futures and swaps each are leveraged investments and, because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for either a futures or swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles and only a portion of those funds should be devoted to any one trade because traders cannot expect to profit on every trade.
Please click here for CME Group’s full disclaimer.